We can't find the internet
Attempting to reconnect
18117.1 PFLS-LS
STR001 as a Novel Treatment for Hearing Loss
Zusammenfassung
STR001 as a Novel Treatment for Hearing Loss
Weitere Texte
Abstract
STR001 is a drug that Strekin aims to develop for the treatment of hearing loss. Damage to sensory hair cells in the inner ear is a primary cause of sensorineural hearing loss. The proposed drug has been shown to activate a target that favorably affects pathways implicated in hearing health. In this project, we conduct translational preclinical research of STR001 to enable fast entry into clinical development and value creation.
Beteiligte
Alexander Bausch
Wirtschaftspartner
alexander.bausch@strekin.com
Strekin AG Alexander Bausch Hochbergerstrasse 60C 4057 Basel BS CH
Daniel Bodmer
Kontaktperson
daniel.bodmer@usb.ch
Universitätsspital Basel Daniel Bodmer Hebelstrasse 20 4031 Basel BS CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2016-02-29
- Enddatum
- 2019-11-30
- Bewilligte Gesamtkosten
- CHF 542745.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%